URGN UroGen Pharma Ltd.
$26.59
▲ 1.30%
43
Value
11
P/E-10.02
8
P/B-10.74
5
P/S9.21
27
EV/EBITDA-11.79
5
Growth
56
Revenue Growth21.4%
83
EPS Growth-7.8%
43
FCF Growth-67.7%
37
Momentum
93
12-Month Return174.4%
100
3-Month Return29.6%
100
1-Month Return39.2%
100
RSI (14)67.09
82
50/200 MABullish
75
Profitability
27
ROE121.5%
75
ROA-52.5%
0
Gross Margin89.9%
72
Operating Margin-77.0%
0
Net Margin-94.8%
0
FCF Yield-12.8%
0
Risk
25
Beta1.59
55
60-Day Volatility66.2%
0
QScore Analysis